Press releases | WebDisclosure

Basculer en Français

10964	Companies
239972	Keywords
168740	Articles
129111	Press releases

Home
Press releases

PRESS RELEASE

published on 03/03/2026 at 07:45, 6 months 8 days ago

Renault S.A. : Déclaration des transactions sur actions propres réalisées du 20 au 25 février 2026
Renault S.A. déclare les transactions sur actions propres du 20 au 25 février 2026 pour le plan d'actionnariat salarié 'Shareplan 2026'. Informations détaillées sur le site de Renault Group

Actions Propres Transactions Rachats D'actions Renault S.A. Shareplan 2026
PRESS RELEASE

published on 03/03/2026 at 07:35, 6 months 8 days ago

Stabilus SE presents product solutions at Enforce Tac and plans significant expansion of its military applications business
Stabilus SE showcases product solutions for military applications at Enforce Tac 2026, plans significant expansion in the sector, anticipates revenue growth from military applications by 2030

Expansion Revenue Growth Stabilus SE Military Applications Enforce Tac 2026
PRESS RELEASE

published on 03/03/2026 at 07:30, 6 months 8 days ago

Nordex Group receives order from Qualitas Energy for 56 MW wind farm in Germany
Nordex Group secures 56 MW wind farm order from Qualitas Energy Deutschland for Wippershainer Höhe project in Germany with 20-year service agreement. Commissioning planned for end of 2027

Germany Nordex Group Wind Farm Service Agreement Qualitas Energy
PRESS RELEASE

published on 03/03/2026 at 07:30, 6 months 8 days ago

Rising Stone met en oeuvre son plan de développement, baptisé Himalaya, et fixe son calendrier financier pour l'année 2026
Rising Stone met en œuvre le plan de développement Himalaya après son introduction en Bourse, se concentrant sur l'acquisition d'actifs fonciers premium et des résultats financiers solides

Résultats Financiers Acquisition Plan De Développement Rising Stone Himalaya
PRESS RELEASE

published on 03/03/2026 at 07:00, 6 months 8 days ago

Cinquième augmentation de capital pour le Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC)
Annonce événementielle: Le Swiss Prime Site Solutions Investment Fund Commercial annonce une cinquième augmentation de capital pour se renforcer et diversifier son portefeuille. Première ouverture aux investisseurs privés depuis introduction en bourse

Augmentation Du Capital Swiss Prime Site Solutions Développement Stratégique Fonds Immobilier Investisseurs Privés
PRESS RELEASE

published on 03/03/2026 at 07:00, 6 months 8 days ago

Fifth capital increase for Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC)
Swiss Prime Site Solutions plans fifth capital increase for the SPSS IFC to strengthen portfolio and attract investors. Detailed terms to be announced soon

Capital Increase Swiss Prime Site Solutions Portfolio Investment Fund Swiss Commercial Properties
PRESS RELEASE

published on 03/03/2026 at 07:00, 6 months 8 days ago

SIG Group AG: Full year results 2025 - stable revenue in a challenging market environment; clear roadmap to drive future value creation
SIG Group AG reports stable revenue for FY 2025 amidst challenging market conditions. Clear roadmap set for future value creation. Mikko Keto appointed new CEO

Revenue Market Conditions SIG Group AG FY 2025 Mikko Keto
PRESS RELEASE

published on 03/03/2026 at 07:00, 6 months 8 days ago

Annual results 2025 - Arbonia increases revenue and EBITDA and proposes Christoph Ganz as new Chairman of the Board of Directors
Arbonia AG reports 12.3% revenue growth and EBITDA increase in 2025. Christoph Ganz proposed as new Chairman of the Board of Directors

Board Of Directors EBITDA Revenue Growth Arbonia AG Christoph Ganz
PRESS RELEASE

published on 03/03/2026 at 07:00, 6 months 8 days ago

VERAXA Biotech Receives 99.57% Approval for Merger - Path to NASDAQ Listing Under «VRXA» Cleared
VERAXA Biotech gains 99.57% approval for merger with Voyager Acquisition Corp., paving the way for NASDAQ listing. Xlife Sciences AG supported the strategic development

Merger Nasdaq Listing Xlife Sciences AG Cancer Therapies VERAXA Biotech
PRESS RELEASE

published on 03/03/2026 at 07:00, 6 months 8 days ago

DocMorris AG announces changes to its Board of Directors
DocMorris AG announces changes to its Board of Directors, with Prof. Stefan Feuerstein, Dr Christian Mielsch, and Rongrong Hu not standing for re-election, proposing the election of new members at the upcoming Annual General Meeting

Board Of Directors Annual General Meeting Personnel Changes DocMorris AG New Members

Accesswire

Published on 09/11/2026 at 04:00, 3 hours 54 minutes ago

Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 9 hours 29 minutes ago

Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 17:46, 14 hours 8 minutes ago

Groete Access Road Nears Completion
Published on 09/10/2026 at 15:20, 16 hours 34 minutes ago

MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 16 hours 54 minutes ago

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

View all ACCESSWIRE

EQS Group

Published on 09/11/2026 at 07:30, 24 minutes ago

NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs
Published on 09/11/2026 at 00:05, 7 hours 49 minutes ago

Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 00:01, 7 hours 53 minutes ago

Club Offers for Travel Enthusiasts in Germany
Published on 09/10/2026 at 22:39, 9 hours 14 minutes ago

EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law
Published on 09/10/2026 at 22:10, 9 hours 43 minutes ago

flatexDEGIRO with changes to the Supervisory Board

Les Echos

Published on 09/11/2026 at 07:00, 54 minutes ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 54 minutes ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 54 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 54 minutes ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 12 hours 24 minutes ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE